Also in this playlist...
This transcript is automatically generated
I'm -- burns with your Fox Business -- -- news from across the pond is sending US stocks lower and European central bank's decision to not take new action to ease the Euro zone's debt crisis.
It's disappointing many investors.
It's also tough day for Bristol-Myers Squibb shares are plunging after the company suspended the study of -- drug intended to treat the liver disease hepatitis C.
And this after a patient suffered heart failure which is raising concerns about the drug's potential.
And the two and a half billion dollars Bristol painted by the company that developed it.
The Securities and Exchange Commission has also charged an executive at Bristol-Myers with insider trading.
And the agency says he executive used confidential information about companies being targeted for potential acquisitions.
What options in those companies.
Not -- latest from the Fox Business Network giving.
Filter by section